Stemline Therapeutics Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Stemline Therapeutics Inc.

Stemline Therapeutics Inc. | Key People and Executives

Ivan Bergstein

Chairman, President & Chief Executive Officer

Mark Sard

Independent Director

Daniel Hume

Independent Director

Darren S. Cline

Independent Director

Ronald Bentsur

Independent Director

Kenneth J. Zuerblis

Independent Director

Alan S. Forman

Independent Director

Ivan Bergstein

Chairman, President & Chief Executive Officer

Kenneth Hoberman

Chief Operating Officer & Secretary

David G. Gionco

Chief Accounting Officer & Vice President-Finance

Mark Sard

Independent Director

Daniel Hume

Independent Director

Darren S. Cline

Independent Director

Ronald E. Bentsur

Independent Director

Kenneth J. Zuerblis

Independent Director

Alan S. Forman

Independent Director

View Profile

Address	750 Lexington Avenue New York New York 10022 United States
Employees	-
Website	http://www.stemline.com
Updated	07/08/2019
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401, is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignancies.